T Cell immune reconstitution after allo-HSCT: key factors and implications

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for hematological malignancies.
• T-cell immune reconstitution is critical for successful allo-HSCT outcomes.
• Understanding T-cell recovery post-transplant is essential for improving patient survival.

Purpose of the Study:

• To review the processes and influencing factors of T-cell recovery post-allo-HSCT.
• To discuss the balance between graft-versus-leukemia (GVL) and graft-versus-host disease (GVHD).
• To explore emerging technologies for enhancing T-cell reconstitution and personalized therapy.

Main Methods:

• Comprehensive literature review of T-cell reconstitution post-allo-HSCT.
• Analysis of factors affecting T-cell recovery, including recipient/donor age, HLA disparity, conditioning, immunosuppression, CMV reactivation, and GVHD.
• Exploration of novel technologies like single-cell multi-omics and AI modeling.

Main Results:

• T-cell recovery follows thymus-independent and thymus-dependent pathways.
• Multiple factors significantly impact T-cell reconstitution dynamics and function.
• T-cell exhaustion and clonal dynamics contribute to relapse risk.
• GVHD and GVL effects present a critical therapeutic balance.

Conclusions:

• Optimizing T-cell reconstitution is key to reducing allo-HSCT complications.
• Targeted interventions and advanced technologies can improve long-term survival.
• Personalized strategies based on T-cell dynamics are crucial for successful transplantation.